ArticleAACE endocrinology and diabetes
Use of Plasmapheresis and Cholestyramine in the Management of Thyroid Storm in the Setting of Cardiogenic Shock and Elevated Liver Enzymes: A Case Report and Review of Literature.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thyroid storm is a rare, life-threatening endocrine emergency, and management becomes particularly challenging in patients with concurrent cardiac and hepatic dysfunction when standard antithyroid therapy is contraindicated. The objective of this report is to describe a patient with thyroid storm complicated by cardiogenic shock and liver injury who was successfully treated using alternative hormone-lowering strategies. Case Report: A 55-year-old woman with severe ischemic cardiomyopathy presented with syncope and was found to have severe thyrotoxicosis following exposure to amiodarone. Laboratory evaluation revealed a thyroid-stimulating hormone level below 0.01 milli-international units per liter (reference range 0.49-4.67) and a free thyroxine level greater than 7.8 ng per deciliter (reference range 0.61-1.6). She developed encephalopathy, acute kidney injury, and marked liver injury. Despite these findings, blood pressure remained within the normal range. Invasive hemodynamic assessment confirmed cardiogenic shock. Antithyroid medications were withheld because of hepatic dysfunction. Management included corticosteroids, cholestyramine, supportive care, and 3 sessions of plasmapheresis. Following 3 sessions of plasmapheresis, she showed marked biochemical and clinical improvement, with normalization of liver function and recovery of renal function, allowing successful discharge. Discussion: This case illustrates the diagnostic difficulty of thyroid storm in patients with advanced heart failure and preserved blood pressure and adds to the limited literature on alternative treatment strategies in the setting of organ dysfunction. Conclusion: This case demonstrates that plasmapheresis combined with cholestyramine may be effective in stabilizing patients with severe thyroid storm when conventional antithyroid therapies cannot be used and highlights the need for heightened clinical suspicion in atypical presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.